MDD Perspectives Deal of the Week!
Medical Device Daily's Obesity Report: Tipping The Market Scales With Biotech Regimens
Key topics covered in this 130-page report include:
- Top current and in-development medical procedures, devices and drugs
- Up-to-date news on competitors – R&D, deals and corporate financial activity
- Med-tech's cutting-edge market advantage over drug developers
- Obesity's contribution to heart disease, cancer, diabetes, stroke, arthritis and more
- More than 70 detailed graphics that characterize and forecast the market
- Defining obesity as a disease, an epidemic, or just an out-of-control condition
- And much more!
Get your copy of this new Medical Device Daily market report for only $299 — PLUS receive the Future of Med-Tech report for FREE!
Click here to learn more!
Technology isn't a silver bullet without human change
By DENNIS TRIBBLE, PharmD, FASHP
Medical Device Daily Contributing Writer
As chief pharmacy officer at Baxa (Englewood, Colorado), Dennis Tribble
is focused on health-system pharmacy operations, patient safety and related medication
safety issues. A pharmacist and software engineer, he is passionate about the need
for a complete restructuring of the pharmacy practice paradigm and the role technology
will play in bringing about that vision. Tribble is a fellow of the
American
Society of Health-System Pharmacists (ASHP; Bethesda, Maryland) Section on Pharmacy
Informatics and Technology and a charter member of the Pharmacy Informatics Task
Force for the Healthcare Information and Management Systems Society
(HIMSS;
Chicago). He also serves as a reviewer on automation for the American Journal
of Health-System Pharmacy.
Technology presents a number of attractive opportunities to reduce the incidence
of error. Why then, has the deployment of this technology not produced some of the
striking reductions in error rates that we expected from this silver bullet?
It has been more than 10 years since the Institute of Medicine (Washington)
published its landmark report "To
Err is Human," yet recent reviews of error rates have shown no dramatic reduction.
Indeed, it would appear that the error rate landscape remains largely unchanged.
One explanation involves the human element of technology deployment, literally
"aiming the silver bullet." When the deployment of the technology fails to accommodate
the requisite human factors, the technology fails. These factors include a number
of human attributes that may confound the deployment of the technology.
Click here
to read the entire story.
What did you think of this article? Do you have an opinion you would like to share with us? We would like to hear from you. Please e-mail us at mddperspectives@bioworld.com. You can also contact MDD Perspectives Editor Lynn Yoffee at lynn.yoffee@ahcmedia.com or 770-361-4789.

Editor's note: In an effort to lighten your day, we now offer a weekly chuckle or two . . .
Women live longer, but not healthier lives than men. Women dominate the healthcare-giver field, but are woefully shortchanged as patients. When it comes to meeting women's healthcare needs, common programs and services, particularly prenatal and delivery care, are more likely to be in position than others such as mental health, sexual violence and cervical cancer screening and treatment. In many countries, sexual and reproductive health services tend to focus exclusively on married women and ignore the needs of unmarried women, children, ethnic minorities and impoverished women.
– Michael J. Harris, Fun Facts Editor
MedTech Investing Conference
Investment dollars down, but interest in sector is strong
By JIM STOMMEN
Medical Device Daily Contributing Writer
MINNEAPOLIS Going by the numbers, it's true that investing in medical technology is down, a status shared by virtually all sectors after the economic meltdown of the past couple of years. But another set of numbers clearly indicates that interest in med-tech investing continues to be strong.
The annual MedTech Investing Conference, held here each May under the sponsorship of
IBF Conferences (Massapequah, New York) and
LifeScience Alley (Minneapolis), last week drew the largest number of attendees in its nine-year history.
The 350 attendees gathered at the Graves 601 Hotel in downtown Minneapolis for the two-day event heard speakers and panelists weigh in on a wide range of questions affecting the industry, with back-to-back panels on the closing day perhaps crystallizing the key points of interest.
Click here
to read the entire story.
|